Clinical Trial Update: Somatropin Treatment to Final Height in Turner Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating somatropin to achieve final height in Turner syndrome has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• Somatropin (Humatrope) (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Turner Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2010-01-27